RC48-ADC Clinical Trials
3 recruitingDrug
Phase 22Phase 11Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2
Advanced Gastroesophageal Adenocarcinoma
Chinese PLA General Hospital42 enrolled3 locationsNCT05403242
Recruiting
Phase 3
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
Urothelial CarcinomaHER2-expressing
RemeGen Co., Ltd.452 enrolled2 locationsNCT05302284
Recruiting
Phase 2
A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Carcinoma
Shanxi Province Cancer Hospital36 enrolled2 locationsNCT06178601